Mid-Illinois Hematology Oncology Associates — Normal, Illinois

Mid-Illinois Hematology Oncology Associates is a clinical research site located in Normal, Illinois, United States 61761.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Mid-Illinois Hematology Oncology Associates has participated in 5 clinical trials.

Therapeutic areas: Gastrointestinal Stromal Tumor, Breast Cancer, Recurrent Large Cell Lung Carcinoma.

Sponsors: National Cancer Institute (NCI), NSABP Foundation Inc, Tragara Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid-Illinois Hematology Oncology Associates?

Mid-Illinois Hematology Oncology Associates has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid-Illinois Hematology Oncology Associates conducted?

Mid-Illinois Hematology Oncology Associates has 5 clinical trials on record. Their work covers Gastrointestinal Stromal Tumor, Breast Cancer, Recurrent Large Cell Lung Carcinoma.

Is Mid-Illinois Hematology Oncology Associates accredited by Crixeo Health?

Yes — Mid-Illinois Hematology Oncology Associates holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Mid-Illinois Hematology Oncology Associates?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.